- Home
- Publications
- Publication Search
- Publication Details
Title
PEGylated Biopharmaceuticals
Authors
Keywords
-
Journal
TOXICOLOGIC PATHOLOGY
Volume 43, Issue 7, Pages 959-983
Publisher
SAGE Publications
Online
2015-08-04
DOI
10.1177/0192623315591171
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of the choroid plexus and blood-CSF barrier
- (2015) Shane A. Liddelow Frontiers in Neuroscience
- Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
- (2014) Johan J.F. Verhoef et al. DRUG DISCOVERY TODAY
- Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
- (2014) Andreas Baumann et al. DRUG DISCOVERY TODAY
- Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
- (2014) Michael S Hershfield et al. ARTHRITIS RESEARCH & THERAPY
- Current challenges and opportunities in nonclinical safety testing of biologics
- (2013) Sven Kronenberg et al. DRUG DISCOVERY TODAY
- Biodistribution and Excretion of Radiolabeled 40kDa Polyethylene Glycol Following Intravenous Administration in Mice
- (2013) Clifford B. Longley et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Physiology of Blood–Brain Interfaces in Relation to Brain Disposition of Small Compounds and Macromolecules
- (2013) N. Strazielle et al. MOLECULAR PHARMACEUTICS
- The Immunogenicity of Polyethylene Glycol: Facts and Fiction
- (2013) Huub Schellekens et al. PHARMACEUTICAL RESEARCH
- High Molecular Weight Polyethylene Glycol Cellular Distribution and PEG-associated Cytoplasmic Vacuolation Is Molecular Weight Dependent and Does Not Require Conjugation to Proteins
- (2013) Daniel G. Rudmann et al. TOXICOLOGIC PATHOLOGY
- Analytical Measurement of PEGylated Molecules
- (2012) Tian-Lu Cheng et al. BIOCONJUGATE CHEMISTRY
- Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
- (2012) Ricardo P Garay et al. Expert Opinion on Drug Delivery
- New approaches to the management of hepatitis C in haemophilia in 2012
- (2012) F. ZOULIM et al. HAEMOPHILIA
- PEGylated therapeutic proteins for haemophilia treatment: a review for haemophilia caregivers
- (2012) I. A. Ivens et al. HAEMOPHILIA
- Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model
- (2011) P. M. van Helden et al. BLOOD
- PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders
- (2011) S. Saenger et al. GROWTH HORMONE & IGF RESEARCH
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
- (2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PEGylation of therapeutic proteins
- (2010) Simona JevsÌevar et al. Biotechnology Journal
- Monocytes and Macrophages Regulate Immunity through Dynamic Networks of Survival and Cell Death
- (2010) Arti Parihar et al. Journal of Innate Immunity
- Emerging PEGylated drugs
- (2009) Jung Seok Kang et al. EXPERT OPINION ON EMERGING DRUGS
- The Impact of PEGylation on Biological Therapies
- (2008) Francesco M Veronese et al. BIODRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More